(Z)-Ethyl 3-(dimethylamino)-2-(3-methylisoxazol-5-yl)acrylate

Catalog No. :
ACRJHL159
CAS No. :
1154030-72-4
Molecular Formula :
C11H16N2O3
Molecular Weight :
224.26

IUPAC Name:ethyl (Z)-3-(dimethylamino)-2-(3-methylisoxazol-5-yl)acrylate

(Z)-Ethyl 3-(dimethylamino)-2-(3-methylisoxazol-5-yl)acrylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$582.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Z)-Ethyl 3-(dimethylamino)-2-(3-methylisoxazol-5-yl)acrylate
IUPAC Nameethyl (Z)-3-(dimethylamino)-2-(3-methylisoxazol-5-yl)acrylate
Molecular FormulaC11H16N2O3
Molecular Weight224.26
SMILESO=C(OCC)/C(C1=CC(C)=NO1)=C\N(C)C
InChI KeyFVOVWVFBCJWIJA-CLFYSBASSA-N
Synonym(Z)-ethyl 3-(diMethylaMino)-2-(3-Methylisoxazol-5-yl)acrylate;ethyl(Z)-3-(dimethylamino)-2-(3-methylisoxazol-5-yl)acrylate;Reaxys ID: 20925707;5-Isoxazoleacetic acid, α-[(dimethylamino)methylene]-3-methyl-, ethyl ester;ethyl-3-(dimethylamino)-2-(3-methylisoxazol-5-yl)acrylate
CAS No.1154030-72-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRJHL159 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRJHL159 route product structure diagram
    ACRJHL1591154030-72-4
Inquiry

2. ACRJHL159 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRJHL159 route product structure diagram
    ACRJHL1591154030-72-4
Inquiry

Comments (0)